Brazilian-U.S. Team's Annexin A1 Peptide Ac2-26 Protected Lab-Grown Human Retinas From High-Glucose Damage
Researchers at the Federal University of São Paulo, São Paulo State University, and the University of Colorado Anschutz grew retinal organoids and retinal ganglion cells from human stem cells and exposed them to high glucose and inflammation, as in diabetic retinopathy. The peptide Ac2-26, a fragment of the anti-inflammatory protein annexin A1, reduced cell death, Müller cell gliosis, and mitochondrial oxidative stress, effects tied to the FPR2 receptor and the p38/NOX4 pathway, the team reports in Biomedicine & Pharmacotherapy; News-Medical covered the work on November 19. The work was done in lab-grown tissue only, and the researchers say animal and human studies come next.